Sugammadex Amomed Europese Unie - IJslands - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - afturköllun taugavöðvablokkunar sem valdið er af rócuronium eða vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Eplerenon Bluefish Filmuhúðuð tafla 25 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

eplerenon bluefish filmuhúðuð tafla 25 mg

bluefish pharmaceuticals ab - eplerenonum inn - filmuhúðuð tafla - 25 mg

Eplerenon Bluefish Filmuhúðuð tafla 50 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

eplerenon bluefish filmuhúðuð tafla 50 mg

bluefish pharmaceuticals ab - eplerenonum inn - filmuhúðuð tafla - 50 mg

Estrogel Hlaup 0,6 mg/g IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

estrogel hlaup 0,6 mg/g

besins healthcare ireland limited - estradiol - hlaup - 0,6 mg/g

Ovestin Tafla 1 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

ovestin tafla 1 mg

aspen pharma trading limited - estriolum inn - tafla - 1 mg

Ovestin Tafla 2 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

ovestin tafla 2 mg

aspen pharma trading limited - estriolum inn - tafla - 2 mg

Pombiliti Europese Unie - IJslands - EMA (European Medicines Agency)

pombiliti

amicus therapeutics europe limited - cipaglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Briumvi Europese Unie - IJslands - EMA (European Medicines Agency)

briumvi

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Akynzeo Europese Unie - IJslands - EMA (European Medicines Agency)

akynzeo

helsinn birex pharmaceuticals ltd - netupitant, palonosetron stutt og long-term - vomiting; neoplasms; nausea; cancer - uppsölulyf og antinauseants, - akynzeo er ætlað í fullorðnir fyrir:koma í veg fyrir bráð og frestað ógleði og uppköstum tengslum með mjög emetogenic cisplatíni byggt krabbamein lyfjameðferð. fyrirbyggja bráð og frestað ógleði og uppköstum tengslum við nokkuð emetogenic krabbamein lyfjameðferð.

Bronchitol Europese Unie - IJslands - EMA (European Medicines Agency)

bronchitol

pharmaxis europe limited - mannitól - cystic fibrosis - hósti og kuldablöndur - bronchitol er ætlað til meðferðar við blöðrubólgu (cf) hjá fullorðnum 18 ára og eldri sem viðbótarmeðferð við bestu umönnun.